Literature DB >> 2055809

Evaluation of the E test, a novel method of quantifying antimicrobial activity.

D F Brown1, L Brown.   

Abstract

The 'E test' is a method for measuring MICs of antimicrobial agents against bacteria and is based on diffusion of a pre-formed antibiotic gradient from a plastic strip. The performance of the E test was evaluated by comparison with a conventional agar dilution MIC method in tests with ten agents and a variety of organisms. Correlation between MICs by the agar dilution and E test methods was good, 98.85% results were within 2 log2 dilution steps in a total of 1304 tests. The E test is technically straightforward as tests are set up in the same way as the disc diffusion method. The versatility and ease of use of the E test make the method an attractive alternative to conventional dilution tests.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055809     DOI: 10.1093/jac/27.2.185

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  45 in total

1.  Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004.

Authors:  W J Munckhof; G Borlace; J D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates.

Authors:  Matteo Bassetti; Louise M Dembry; Patricia A Farrel; Deborah A Callan; Vincent T Andriole
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Evaluation of the E test in testing susceptibility of Pseudomonas aeruginosa to tobramycin.

Authors:  H Rautelin; I Renkonen; O V Renkonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

4.  Comparison of the E test and microdilution for detection of beta-lactam-resistant mutants that are stably derepressed for type I beta-lactamase.

Authors:  C C Knapp; J A Washington
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

Review 5.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution.

Authors:  Eiman M Mokaddas; Nathaneal O Salako; Leeba Philip; Vincent O Rotimi
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

7.  Swarm-cell differentiation in Salmonella enterica serovar typhimurium results in elevated resistance to multiple antibiotics.

Authors:  Wook Kim; Teresa Killam; Vandana Sood; Michael G Surette
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

8.  Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria.

Authors:  L Martínez-Martínez; M C Ortega; A I Suárez
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.

Authors:  S Chaves; M Gadanho; R Tenreiro; J Cabrita
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

10.  Does in vitro susceptibility predict clinical outcome in bacterial keratitis?

Authors:  Aiyin Chen; Lalitha Prajna; Muthiah Srinivasan; Rajendran Mahalakshmi; John P Whitcher; Stephen McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2008-01-22       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.